I guess we knew there were issues just that the company refused to comment on any front. Makes these results even stranger although reading between the lines maybe this data reveals why they have "pivoted" from burns to foot ulcers. Maybe burns have additional complications that werent condusive to progressing. Maybe simply too painful on application as they seem to emphasize no pain in this update?
- Forums
- ASX - By Stock
- Ann: Positive Patients Update - Special Access Scheme
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.15%
!
30.5¢

I guess we knew there were issues just that the company refused...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $54.63K | 174.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 28921 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 0.305 |
4 | 17833 | 0.300 |
2 | 10000 | 0.295 |
11 | 90433 | 0.290 |
2 | 135000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 28921 | 1 |
0.340 | 24538 | 1 |
0.350 | 30000 | 2 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online